Scientific Opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006

被引:53
|
作者
Agostoni, Carlo [1 ]
Bresson, Jean-Louis [1 ]
Fairweather-Tait, Susan [1 ]
Flynn, Albert [1 ]
Golly, Ines [1 ]
Korhonen, Harmu [1 ]
Lagiou, Pagona [1 ]
Lovik, Martinus [1 ]
Marchelli, Rosangela [1 ]
Martin, Ambroise [1 ]
Moseley, Bevan [1 ]
Neuhaeuser-Berthold, Monika [1 ]
Przyrembel, Hildegard [1 ]
Salminen, Seppo [1 ]
Sanz, Yolanda [1 ]
Strain, Sean [1 ]
Strobel, Stephan [1 ]
Tetens, Inge [1 ]
Tome, Daniel [1 ]
van Loveren, Hendrik [1 ]
Verhagen, Hans [1 ]
机构
[1] EFSA, Parma, Italy
关键词
Cocoa flavanols; endothelium-dependent vasodilation; health claims;
D O I
10.2903/j.efsa.2012.2809
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Following an application from Barry Callebaut Belgium nv, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation. Cocoa flavanols are sufficiently characterised. The claimed effect is "help maintain endothelium-dependent vasodilation which contributes to healthy blood flow". The target population proposed by the applicant is the general healthy adult population. The Panel considers that maintenance of normal endothelium-dependent vasodilation is a beneficial physiological effect. In weighing the evidence, the Panel took into account that cocoa flavanols consumed for 12 weeks have been shown to increase fasting ED-FMD significantly in the target population in one human intervention study, that in another study the effect was dose-dependent and occurred after one week of consumption, that the effect was supported by two additional studies, and that it was also observed in two out of three studies in patients under pharmacological treatment for coronary artery disease, although the mechanisms by which regular consumption of cocoa flavanols may induce a sustained effect on fasting ED-FMD are unknown. The Panel concludes that a cause and effect relationship has been established between the consumption of cocoa flavanols and maintenance of normal endothelium-dependent vasodilation. The following wording reflects the scientific evidence: "Cocoa flavanols help maintain endothelium-dependent vasodilation, which contributes to normal blood flow". In order to obtain the claimed effect, 200 mg of cocoa flavanols should be consumed daily. This amount could be provided by 2.5 g of high-flavanol cocoa powder or 10 g of high-flavanol dark chocolate, both of which can be consumed in the context of a balanced diet. The target population is the general population. (C) European Food Safety Authority, 2012
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Scientific Opinion on the modification of the authorisation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006 following a request in accordance with Article 19 of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjoedin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2014, 12 (05)
  • [2] Black tea and maintenance of normal endothelium-dependent vasodilation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Turck, Dominique
    Bresson, Jean-Louis
    Burlingame, Barbara
    Dean, Tara
    Fairweather-Tait, Susan
    Heinonen, Marina
    Hirsch-Ernst, Karen Ildico
    Mangelsdor, Inge
    McArdle, Harry J.
    Naska, Androniki
    Neuhauser-Berthold, Monika
    Nowicka, Grazyna
    Pentieva, Kristina
    Sanz, Yolanda
    Sjodin, Anders
    Stern, Martin
    Tome, Daniel
    Van Loveren, Henk
    Vinceti, Marco
    Willatts, Peter
    Martin, Ambroise
    Strain, Sean
    Siani, Alfonso
    EFSA JOURNAL, 2018, 16 (01)
  • [3] Scientific Opinion on the substantiation of a health claim related to glucosamine and maintenance of joints pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhauser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (12)
  • [4] Scientific Opinion on the substantiation of a health claim related to glucosamine and maintenance of normal joint cartilage pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2012, 10 (05)
  • [5] Scientific Opinion on the substantiation of a health claim related to cytidine 5'-diphosphocholine and maintenance of normal vision pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjoedin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2014, 12 (02)
  • [6] Scientific Opinion on the substantiation of a health claim related to caffeine and increased alertness pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjoedin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2014, 12 (02)
  • [7] Scientific Opinion on the substantiation of a health claim related to zinc and normal growth pursuant to Article 14 of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Canani, Roberto Berni
    Fairweather-Tait, Susan
    Heinonen, Marina
    Korhonen, Hannu
    La Vieille, Sebastien
    Marchelli, Rosangela
    Martin, Ambroise
    Naska, Androniki
    Neuhaeuser-Berthold, Monika
    Nowicka, Grazyna
    Sanz, Yolanda
    Siani, Alfonso
    Sjodin, Anders
    Stern, Martin
    Strain, Sean
    Tetens, Inge
    Tome, Daniel
    Turck, Dominique
    Verhagen, Hans
    EFSA JOURNAL, 2014, 12 (11)
  • [8] Scientific Opinion on the substantiation of a health claim related to KF2BL20 and maintenance of normal hair pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Harmu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2012, 10 (07)
  • [9] Scientific Opinion on the substantiation of a health claim related to Opti(EFAX)(TM) and maintenance of normal blood concentrations of triglycerides pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Harmu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2012, 10 (07)